Related references
Note: Only part of the references are listed.The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery
Samuel A. Smith et al.
BIOCONJUGATE CHEMISTRY (2019)
Intralymphatic Immunotherapy: Update and Unmet Needs
Gabriela Senti et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Qian Chen et al.
NATURE NANOTECHNOLOGY (2019)
What, Why, Where, and When: Bringing Timing to Immuno-Oncology
Adrienne M. Rothschilds et al.
TRENDS IN IMMUNOLOGY (2019)
Delivery of 5′-triphosphate RNA with endosomolytic nanoparticles potently activates RIG-I to improve cancer immunotherapy
Max E. Jacobson et al.
BIOMATERIALS SCIENCE (2019)
Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells
Jeonghyun Ahn et al.
CANCER CELL (2018)
Radiation therapy and immunotherapy: what is the optimal timing or sequencing?
Maureen L. Aliru et al.
IMMUNOTHERAPY (2018)
Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases
Chun Gwon Park et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs
Ludger Johannes et al.
NUCLEIC ACID THERAPEUTICS (2018)
Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies
Sandra Iurescia et al.
FRONTIERS IN IMMUNOLOGY (2018)
Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers
David L. Elion et al.
CANCER RESEARCH (2018)
The importance of correctly timing cancer immunotherapy
Elham Beyranvand Nejad et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally
M. Angela Aznar et al.
JOURNAL OF IMMUNOLOGY (2017)
Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies
Leo L. Wang et al.
ADVANCED HEALTHCARE MATERIALS (2017)
Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events
Jun Ishihara et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Intratumoral immunotherapy: using the tumor as the remedy
A. Marabelle et al.
ANNALS OF ONCOLOGY (2017)
Solid-phase supported design of carriers for therapeutic nucleic acid delivery
Ana Krhac Levacic et al.
BIOSCIENCE REPORTS (2017)
Diblock Copolymer Hydrophobicity Facilitates Efficient Gene Silencing and Cytocompatible Nanoparticle-Mediated siRNA Delivery to Musculoskeletal Cell Types
Dominic W. Malcolm et al.
BIOMACROMOLECULES (2017)
Controlled and sustained delivery of siRNA/NPs from hydrogels expedites bone fracture healing
Yuchen Wang et al.
BIOMATERIALS (2017)
Delivering safer immunotherapies for cancer
Lauren Milling et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody
Chao Wang et al.
ADVANCED MATERIALS (2016)
RNA Interference (RNAi)-Based Therapeutics: Delivering on the Promise?
Maggie L. Bobbin et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
Local Delivery of PHD2 siRNA from ROS-Degradable Scaffolds to Promote Diabetic Wound Healing
John R. Martin et al.
ADVANCED HEALTHCARE MATERIALS (2016)
Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy
Kristina H. Young et al.
PLOS ONE (2016)
Preclinical and clinical development of siRNA-based therapeutics
Gulnihal Ozcan et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Effect of vaccine administration modality on immunogenicity and efficacy
Lu Zhang et al.
EXPERT REVIEW OF VACCINES (2015)
On-demand drug delivery from local depots
Yevgeny Brudno et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Technologies for controlled, local delivery of siRNA
Samantha M. Sarett et al.
JOURNAL OF CONTROLLED RELEASE (2015)
In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf
Linda Hammerich et al.
MOLECULAR ONCOLOGY (2015)
Immunomodulatory spherical nucleic acids
Aleksandar F. Radovic-Moreno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Identification of Immune Factors Regulating Antitumor Immunity Using Polymeric Vaccines with Multiple Adjuvants
Omar A. Ali et al.
CANCER RESEARCH (2014)
Intratumoral Immunization: A New Paradigm for Cancer Therapy
Aurelien Marabelle et al.
CLINICAL CANCER RESEARCH (2014)
Quaternized starch-based carrier for siRNA delivery: From cellular uptake to gene silencing
Eliz Amar-Lewis et al.
JOURNAL OF CONTROLLED RELEASE (2014)
pH-Responsive Nanoparticle Vaccines for Dual-Delivery of Antigens and Immunostimulatory Oligonucleotides
John T. Wilson et al.
ACS NANO (2013)
A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW/F1 mice
Fu-Gang Zhu et al.
AUTOIMMUNITY (2013)
Localized Immunotherapy via Liposome-Anchored Anti-CD137+IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
Brandon Kwong et al.
CANCER RESEARCH (2013)
Turning Tumors into Vaccines: Co-opting the Innate Immune System
Jasper G. van den Boorn et al.
IMMUNITY (2013)
A Toll-Like Receptor 7, 8, and 9 Antagonist Inhibits Th1 and Th17 Responses and Inflammasome Activation in a Model of IL-23-Induced Psoriasis
Weiwen Jiang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Nanoparticle-mediated Gene Silencing Confers Radioprotection to Salivary Glands In Vivo
Szilvia Arany et al.
MOLECULAR THERAPY (2013)
Newly described pattern recognition receptors team up against intracellular pathogens
Petr Broz et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Sustained local delivery of siRNA from an injectable scaffold
Christopher E. Nelson et al.
BIOMATERIALS (2012)
PLGA-based nanoparticles: An overview of biomedical applications
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy
Brandon Kwong et al.
BIOMATERIALS (2011)
Biodegradable CpG DNA hydrogels for sustained delivery of doxorubicin and immunostimulatory signals in tumor-bearing mice
Makiya Nishikawa et al.
BIOMATERIALS (2011)
High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: Quality by design optimization and characterization
Dongmei Cun et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAV™ safety and efficacy
Curtis Cooper et al.
EXPERT REVIEW OF VACCINES (2011)
Timing Is Critical for an Effective Anti-Metastatic Immunotherapy: The Decisive Role of IFNγ/STAT1-Mediated Activation of Autophagy
Jun Yan et al.
PLOS ONE (2011)
In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles
Christopher M. Jewell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Hirenkumar K. Makadia et al.
POLYMERS (2011)
pH-Responsive Polymeric Micelle Carriers for siRNA Drugs
A. J. Convertine et al.
BIOMACROMOLECULES (2010)
Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery
Dongmei Cun et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Joshua D. Brody et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Polymeric nanoparticles for siRNA delivery and gene silencing
Yogesh Patil et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
Development of a novel endosomolytic diblock copolymer for siRNA delivery
Anthony J. Convertine et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA
Kim A. Woodrow et al.
NATURE MATERIALS (2009)
Infection-mimicking materials to program dendritic cells in situ
Omar A. Ali et al.
NATURE MATERIALS (2009)
Knocking down barriers: advances in siRNA delivery
Kathryn A. Whitehead et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Biodegradable polymers as non-viral carriers for plasmid DNA delivery
Jordy Luten et al.
JOURNAL OF CONTROLLED RELEASE (2008)
5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma
Hendrik Poeck et al.
NATURE MEDICINE (2008)
Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres
Shirui Mao et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models
Xinmei Zhu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging
DW Bartlett et al.
NUCLEIC ACIDS RESEARCH (2006)
Designing materials for biology and medicine
R Langer et al.
NATURE (2004)
Controlled release systems for DNA delivery
AK Pannier et al.
MOLECULAR THERAPY (2004)
Repeated immunization with plasmid DNA formulated in poly (lactide-co-glycolide) microparticles is well tolerated and stimulates durable T cell responses to the tumor-associated antigen cytochrome P4501B1
TM Luby et al.
CLINICAL IMMUNOLOGY (2004)
Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies
A Khan et al.
JOURNAL OF DRUG TARGETING (2004)
Brush-like branched biodegradable polyesters, part III - Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid)
KF Pistel et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles
H Cohen et al.
GENE THERAPY (2000)
Share Paper
